US Stock MarketDetailed Quotes

APYX Apyx Medical

Watchlist
  • 1.680
  • -0.010-0.59%
Close Dec 13 16:00 ET
63.24MMarket Cap-2.05P/E (TTM)

Apyx Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-220.13%-4.44M
10.78%-4.33M
-237.11%-6.34M
74.12%-5.25M
51.17%-2.21M
168.96%3.7M
17.37%-4.85M
58.37%-1.88M
-94.09%-20.28M
-2,216.82%-4.53M
Net income from continuing operations
-1.05%-4.72M
-546.32%-6.59M
-114.89%-7.59M
19.02%-18.85M
-58.68%-9.62M
19.33%-4.68M
81.30%-1.02M
40.82%-3.53M
-53.14%-23.28M
-201.74%-6.07M
Operating gains losses
-22.22%28K
--0
--20K
642.67%557K
321,400.00%3.21M
24.14%36K
----
----
56.25%75K
-200.00%-1K
Depreciation and amortization
-22.58%144K
3.31%156K
-22.66%157K
-22.25%692K
-24.75%152K
-13.89%186K
-38.87%151K
-9.78%203K
-1.44%890K
-11.79%202K
Other non cash items
39.11%249K
54.27%253K
276.12%252K
--632K
--222K
--179K
--164K
--67K
----
----
Change In working capital
-119.17%-1.24M
121.13%700K
-301.92%-315K
206.25%5.54M
637.71%2.25M
524.14%6.45M
-27.33%-3.31M
123.08%156K
-183.07%-5.22M
-346.47%-419K
-Change in receivables
-104.40%-308K
87.23%-291K
134.60%1.48M
97.07%3.97M
-1.99%-1.38M
517.37%7M
-229.36%-2.28M
32.63%630K
141.21%2.02M
21.27%-1.36M
-Change in inventory
366.92%355K
218.55%409K
-84.30%138K
126.20%1.46M
917.31%1.06M
94.65%-133K
87.75%-345K
336.93%879K
-94.75%-5.57M
111.86%104K
-Change in prepaid assets
80.66%-124K
146.45%425K
-71.91%241K
64.05%-188K
25,600.00%510K
-2,389.29%-641K
23.62%-915K
32.20%858K
-138.60%-523K
-100.15%-2K
-Change in payables and accrued expense
-626.82%-1.16M
-30.22%157K
1.76%-2.17M
126.38%301K
147.84%2.07M
211.68%220K
164.47%225K
-54.72%-2.21M
-125.08%-1.14M
-40.00%834K
Cash from discontinued investing activities
Operating cash flow
-220.13%-4.44M
10.78%-4.33M
-237.11%-6.34M
74.12%-5.25M
51.17%-2.21M
168.96%3.7M
17.37%-4.85M
58.37%-1.88M
-94.09%-20.28M
-2,216.82%-4.53M
Investing cash flow
Cash flow from continuing investing activities
12.07%-153K
-104.06%-289K
68.18%-35K
766.73%6.73M
34.51%-93K
7.45%-174K
1,873.32%7.11M
60.57%-110K
-39.70%-1.01M
57.23%-142K
Net PPE purchase and sale
12.07%-153K
-104.06%-289K
68.18%-35K
766.73%6.73M
34.51%-93K
7.45%-174K
1,873.32%7.11M
60.57%-110K
-39.70%-1.01M
57.23%-142K
Cash from discontinued investing activities
Investing cash flow
12.07%-153K
-104.06%-289K
68.18%-35K
766.73%6.73M
34.51%-93K
7.45%-174K
1,873.32%7.11M
60.57%-110K
-39.70%-1.01M
57.23%-142K
Financing cash flow
Cash flow from continuing financing activities
-103.05%-5K
-110.87%-5K
-100.06%-5K
14,723.04%32.17M
238,540.00%23.84M
29.13%164K
2,200.00%46K
8,177.55%8.11M
804.17%217K
74.36%-10K
Net issuance payments of debt
99.17%-5K
50.00%-5K
-100.05%-5K
23,775.00%35.04M
257,920.00%25.78M
-1,896.67%-599K
81.48%-10K
18,370.37%9.87M
37.82%-148K
82.46%-10K
Proceeds from stock option exercised by employees
--0
----
----
-76.44%86K
---586K
292.36%616K
----
----
444.78%365K
--0
Net other financing activities
----
----
----
---2.96M
---1.35M
--147K
--0
---1.75M
----
----
Cash from discontinued financing activities
Financing cash flow
-103.05%-5K
-110.87%-5K
-100.06%-5K
14,723.04%32.17M
238,540.00%23.84M
29.13%164K
2,200.00%46K
8,177.55%8.11M
804.17%217K
74.36%-10K
Net cash flow
Beginning cash position
76.84%32.68M
129.36%37.28M
328.30%43.65M
-66.98%10.19M
49.22%22.13M
-7.90%18.48M
-38.04%16.26M
-66.98%10.19M
-26.35%30.87M
-51.99%14.83M
Current changes in cash
-224.74%-4.6M
-300.56%-4.62M
-204.25%-6.38M
259.69%33.65M
560.04%21.54M
167.99%3.69M
136.76%2.31M
230.26%6.12M
-89.03%-21.07M
-2,882.17%-4.68M
Effect of exchange rate changes
-116.13%-67K
123.46%19K
118.97%11K
-148.35%-191K
-151.22%-21K
-116.23%-31K
-181.00%-81K
-192.06%-58K
283.50%395K
-68.22%41K
End cash Position
26.56%28.01M
76.84%32.68M
129.36%37.28M
328.30%43.65M
328.30%43.65M
49.22%22.13M
-7.90%18.48M
-38.04%16.26M
-66.98%10.19M
-66.98%10.19M
Free cash flow
-230.41%-4.59M
7.79%-4.62M
-220.24%-6.38M
72.84%-5.78M
50.66%-2.31M
163.48%3.52M
20.17%-5.01M
58.49%-1.99M
-90.57%-21.29M
-3,859.32%-4.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -220.13%-4.44M10.78%-4.33M-237.11%-6.34M74.12%-5.25M51.17%-2.21M168.96%3.7M17.37%-4.85M58.37%-1.88M-94.09%-20.28M-2,216.82%-4.53M
Net income from continuing operations -1.05%-4.72M-546.32%-6.59M-114.89%-7.59M19.02%-18.85M-58.68%-9.62M19.33%-4.68M81.30%-1.02M40.82%-3.53M-53.14%-23.28M-201.74%-6.07M
Operating gains losses -22.22%28K--0--20K642.67%557K321,400.00%3.21M24.14%36K--------56.25%75K-200.00%-1K
Depreciation and amortization -22.58%144K3.31%156K-22.66%157K-22.25%692K-24.75%152K-13.89%186K-38.87%151K-9.78%203K-1.44%890K-11.79%202K
Other non cash items 39.11%249K54.27%253K276.12%252K--632K--222K--179K--164K--67K--------
Change In working capital -119.17%-1.24M121.13%700K-301.92%-315K206.25%5.54M637.71%2.25M524.14%6.45M-27.33%-3.31M123.08%156K-183.07%-5.22M-346.47%-419K
-Change in receivables -104.40%-308K87.23%-291K134.60%1.48M97.07%3.97M-1.99%-1.38M517.37%7M-229.36%-2.28M32.63%630K141.21%2.02M21.27%-1.36M
-Change in inventory 366.92%355K218.55%409K-84.30%138K126.20%1.46M917.31%1.06M94.65%-133K87.75%-345K336.93%879K-94.75%-5.57M111.86%104K
-Change in prepaid assets 80.66%-124K146.45%425K-71.91%241K64.05%-188K25,600.00%510K-2,389.29%-641K23.62%-915K32.20%858K-138.60%-523K-100.15%-2K
-Change in payables and accrued expense -626.82%-1.16M-30.22%157K1.76%-2.17M126.38%301K147.84%2.07M211.68%220K164.47%225K-54.72%-2.21M-125.08%-1.14M-40.00%834K
Cash from discontinued investing activities
Operating cash flow -220.13%-4.44M10.78%-4.33M-237.11%-6.34M74.12%-5.25M51.17%-2.21M168.96%3.7M17.37%-4.85M58.37%-1.88M-94.09%-20.28M-2,216.82%-4.53M
Investing cash flow
Cash flow from continuing investing activities 12.07%-153K-104.06%-289K68.18%-35K766.73%6.73M34.51%-93K7.45%-174K1,873.32%7.11M60.57%-110K-39.70%-1.01M57.23%-142K
Net PPE purchase and sale 12.07%-153K-104.06%-289K68.18%-35K766.73%6.73M34.51%-93K7.45%-174K1,873.32%7.11M60.57%-110K-39.70%-1.01M57.23%-142K
Cash from discontinued investing activities
Investing cash flow 12.07%-153K-104.06%-289K68.18%-35K766.73%6.73M34.51%-93K7.45%-174K1,873.32%7.11M60.57%-110K-39.70%-1.01M57.23%-142K
Financing cash flow
Cash flow from continuing financing activities -103.05%-5K-110.87%-5K-100.06%-5K14,723.04%32.17M238,540.00%23.84M29.13%164K2,200.00%46K8,177.55%8.11M804.17%217K74.36%-10K
Net issuance payments of debt 99.17%-5K50.00%-5K-100.05%-5K23,775.00%35.04M257,920.00%25.78M-1,896.67%-599K81.48%-10K18,370.37%9.87M37.82%-148K82.46%-10K
Proceeds from stock option exercised by employees --0---------76.44%86K---586K292.36%616K--------444.78%365K--0
Net other financing activities ---------------2.96M---1.35M--147K--0---1.75M--------
Cash from discontinued financing activities
Financing cash flow -103.05%-5K-110.87%-5K-100.06%-5K14,723.04%32.17M238,540.00%23.84M29.13%164K2,200.00%46K8,177.55%8.11M804.17%217K74.36%-10K
Net cash flow
Beginning cash position 76.84%32.68M129.36%37.28M328.30%43.65M-66.98%10.19M49.22%22.13M-7.90%18.48M-38.04%16.26M-66.98%10.19M-26.35%30.87M-51.99%14.83M
Current changes in cash -224.74%-4.6M-300.56%-4.62M-204.25%-6.38M259.69%33.65M560.04%21.54M167.99%3.69M136.76%2.31M230.26%6.12M-89.03%-21.07M-2,882.17%-4.68M
Effect of exchange rate changes -116.13%-67K123.46%19K118.97%11K-148.35%-191K-151.22%-21K-116.23%-31K-181.00%-81K-192.06%-58K283.50%395K-68.22%41K
End cash Position 26.56%28.01M76.84%32.68M129.36%37.28M328.30%43.65M328.30%43.65M49.22%22.13M-7.90%18.48M-38.04%16.26M-66.98%10.19M-66.98%10.19M
Free cash flow -230.41%-4.59M7.79%-4.62M-220.24%-6.38M72.84%-5.78M50.66%-2.31M163.48%3.52M20.17%-5.01M58.49%-1.99M-90.57%-21.29M-3,859.32%-4.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Abits
ABTS
+9.91%
Bakkt Holdings
BKKT
+5.92%
Riot Platforms
RIOT
+5.35%
Canaan
CAN
+3.62%
CATHEDRA BITCOIN INC
CBTTF
+1.62%

Unlock the Full List